
LGND
Healthcare · Biotechnology · $6.18B market cap
$308.79-7.48 (-2.4%)Nov 13, 4:03 PM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · -4.7% over 90 days · 30-day revisions 1 up, 3 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Oct 29, 2026 | Before the open | 1.42 | -1.43 | -200.7% |
| Aug 6, 2026 | Before the open | 1.34 | 2.22 | +65.7% |
| May 7, 2026 | Before the open | 1.80 | 1.63 | -9.4% |
| Feb 26, 2026 | Time not confirmed | 0.63 | 2.12 | +236.5% |
| Nov 6, 2025 | Before the open | 1.93 | 3.09 | +60.1% |
| Aug 7, 2025 | Before the open | 0.21 | 0.24 | +14.3% |
| May 8, 2025 | Before the open | 1.21 | 1.33 | +9.9% |
| Feb 25, 2025 | Before the open | 1.19 | 1.27 | +6.7% |
| Nov 7, 2024 | Before the open | 1.35 | 1.84 | +36.3% |
| Aug 6, 2024 | After the close | 1.06 | 1.40 | +32.1% |
| May 8, 2024 | After the close | 0.83 | 1.20 | +44.6% |
| Feb 27, 2024 | Before the open | 0.66 | 1.38 | +109.1% |
| Nov 8, 2023 | After the close | 0.62 | 1.02 |
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against…
| +64.5% |
| Aug 8, 2023 | After the close | 0.66 | 1.42 | +115.2% |
| May 4, 2023 | After the close | 0.89 | 2.28 | +156.2% |
| Feb 22, 2023 | After the close | 1.19 | 1.36 | +14.3% |
| Nov 7, 2022 | After the close | 0.43 | 1.31 | +204.7% |
| Aug 8, 2022 | After the close | 0.43 | 1.03 | +139.5% |
| May 4, 2022 | After the close | 0.66 | 0.76 | +15.2% |
| Feb 17, 2022 | After the close | 1.37 | 1.80 | +31.4% |
| Nov 9, 2021 | After the close | 1.04 | 1.58 | +51.9% |
| Jul 29, 2021 | After the close | 1.36 | 1.63 | +19.9% |
| May 3, 2021 | After the close | 1.13 | 1.41 | +24.8% |
| Feb 3, 2021 | Before the open | 1.09 | 1.62 | +48.6% |
| Oct 30, 2020 | Before the open | 0.98 | 1.04 | +6.1% |
| Aug 3, 2020 | Before the open | 0.76 | 1.00 | +31.6% |
| May 6, 2020 | After the close | 0.66 | 0.89 | +34.8% |
| Feb 6, 2020 | After the close | 0.65 | 0.71 | +9.2% |
| Nov 5, 2019 | After the close | 0.62 | 0.49 | -21.0% |
| Jul 30, 2019 | Before the open | 0.55 | 0.68 | +23.6% |
| May 2, 2019 | After the close | 15.45 | 1.16 | -92.5% |
| Feb 7, 2019 | After the close | 1.22 | 1.70 | +39.3% |
| Nov 8, 2018 | Before the open | 1.03 | 1.32 | +28.2% |
| Aug 6, 2018 | After the close | 2.38 | 2.59 | +8.8% |
| May 8, 2018 | After the close | 1.26 | 1.55 | +23.0% |
| Feb 21, 2018 | After the close | 1.19 | 1.31 | +10.1% |